6-[4-(2-nitro-phenyl)oxazol-2-yl]-hexanoic acid ethyl ester | 847267-06-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 6-[4-(2-nitro-phenyl)oxazol-2-yl]-hexanoic acid ethyl ester
• 英文别名: 6-[4-(2-Nitro-phenyl)-oxazol-2-yl]-hexanoic acid ethyl ester；ethyl 6-[4-(2-nitrophenyl)-1,3-oxazol-2-yl]hexanoate
• CAS: 847267-06-5
• 化学式: C₁₇H₂₀N₂O₅
• 分子量: 332.356
• InChiKey: UNRLAHUQUSIABI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  24
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.41
• 拓扑面积：
  98.2
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  4-[4-(2-nitro-phenyl)-oxazol-2-yl]-butyric acid methyl ester 、 2-溴-2′-硝基苯乙酮 、 6-carbamoyl-hexanoic acid ethyl ester 以gives 6-[4-(2-nitro-phenyl)-oxazol-2-yl]-hexanoic acid ethyl ester (3.19 g, 26%)的产率得到6-[4-(2-nitro-phenyl)oxazol-2-yl]-hexanoic acid ethyl ester
  参考文献：
  名称：

  Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide

  摘要：

  本发明涉及一种新型化合物、方法和配方，用于口服给药GLP-1化合物或MC4激动剂肽。

  公开号：

  US20080214448A1

文献信息

• [EN] COMPOUNDS, METHODS AND FORMULATIONS FOR THE ORAL DELIVERY OF A GLUCAGON LIKE PEPTIDE (GLP)-1 COMPOUND OR AN MELANOCORTIN 4 RECEPTOR (MC4) AGONIST PEPTIDE<br/>[FR] COMPOSES, PROCEDES ET PREPARATIONS DESTINES A L'APPORT ORAL D'UN COMPOSE PEPTIDIQUE DE TYPE GLUCAGON (GLP-1) OU D'UN PEPTIDE AGONISTE DU RECEPTEUR 4 DE MELANOCORTINE (MC4)
  申请人：LILLY CO ELI

  公开号：WO2005019184A1

  公开（公告）日：2005-03-03

  The present invention relates to novel compounds, methods, and formulations useful for the oral delivery of a GLP-1 compound or an MC4 agonist peptide.

  本发明涉及用于口服给荷GLP-1化合物或MC4激动剂肽的新化合物、方法和配方。
• COMPOUNDS, METHODS AND FORMULATIONS FOR THE ORAL DELIVERY OF A GLUCAGON-LIKE PEPTIDE (GLP-1) COMPOUND OR A MELANOCORTIN-4 RECEPTOR (MC4) AGONIST PEPTIDE
  申请人：HERR Robert Jason

  公开号：US20100120876A1

  公开（公告）日：2010-05-13

  The present invention relates to novel compounds, methods, and formulations useful for the oral delivery of a GLP-1 compound or an MC4 agonist peptide.

  本发明涉及一种新型化合物、方法和配方，用于口服给药GLP-1化合物或MC4激动剂肽。
• Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide
  申请人：Herr Robert Jason

  公开号：US08552039B2

  公开（公告）日：2013-10-08

  The present invention relates to novel compounds, methods, and formulations useful for the oral delivery of a GLP-1 compound or an MC4 agonist peptide.

  本发明涉及一种新型化合物、方法和制剂，用于口服给药GLP-1化合物或MC4激动剂肽。
• COMPOUNDS, METHODS AND FORMULATIONS FOR THE ORAL DELIVERY OF A GLUCAGON-LIKE PEPTIDE (GLP-1) COMPOUND OR A MELANOCORTIN-4 RECEPTOR (MIC4) AGONIST PEPTIDE
  申请人：Emisphere Technologies, Inc.

  公开号：US20140031287A1

  公开（公告）日：2014-01-30

  The present invention relates to novel compounds, methods, and formulations useful for the oral delivery of a GLP-1 compound or an MC4 agonist peptide.

  本发明涉及新型化合物、方法和配方，用于口服给药GLP-1化合物或MC4激动剂肽。
• Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide
  申请人：Emisphere Technologies, Inc.

  公开号：US07662771B2

  公开（公告）日：2010-02-16

  The present invention relates to novel compounds, methods, and formulations useful for the oral delivery of a GLP-1 compound or an MC4 agonist peptide.

  本发明涉及一种新型化合物、方法和配方，用于口服给药GLP-1化合物或MC4激动剂肽。